Cargando…

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain

BACKGROUND: A recent randomized‐withdrawal, active‐ and placebo‐controlled, double‐blind phase 3 study showed that tapentadol prolonged release (PR) was effective and well tolerated for managing moderate to severe, chronic malignant tumour‐related pain in patients who were opioid naive or dissatisfi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kress, H.G., Koch, E.D., Kosturski, H., Steup, A., Karcher, K., Dogan, C., Etropolski, M., Eerdekens, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071659/ https://www.ncbi.nlm.nih.gov/pubmed/27062079 http://dx.doi.org/10.1002/ejp.875

Ejemplares similares

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release
por: Imanaka, Keiichiro, et al.
Publicado: (2014)

Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
por: Samolsky Dekel, Boaz G., et al.
Publicado: (2015)

Comparison of tapentadol with tramadol for analgesia after cardiac surgery
por: Iyer, Srinivas Kalyanaraman, et al.
Publicado: (2015)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021)

Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
por: Bacallao, Jorge, et al.
Publicado: (2016)

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease
por: Coluzzi, Flaminia, et al.
Publicado: (2015)

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18
por: Finkel, Julia C, et al.
Publicado: (2019)

Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis
por: Biondi, David M., et al.
Publicado: (2014)

A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy
por: Schwartz, Sherwyn, et al.
Publicado: (2014)

Repeated Administration of Clinical Doses of Tramadol and Tapentadol Causes Hepato- and Nephrotoxic Effects in Wistar Rats
por: Barbosa, Joana, et al.
Publicado: (2020)

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study
por: Steigerwald, Ilona, et al.
Publicado: (2012)

Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population
por: Watson, Estelle, et al.
Publicado: (2019)

Tapentadol versus tramadol in the management of low back pain in the emergency department: Impact of use on the need for reassessments
por: Guillén-Astete, Carlos A., et al.
Publicado: (2017)

Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats
por: Domínguez-Oliva, Adriana, et al.
Publicado: (2021)

Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients
por: Roulet, Lucien, et al.
Publicado: (2021)

Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving
por: Barbosa, Joana, et al.
Publicado: (2023)

Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
por: Khalil, Feras, et al.
Publicado: (2020)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Tapentadol: a new option for the treatment of cancer and noncancer pains
por: Dickenson, Anthony H, et al.
Publicado: (2019)

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain
por: Steigerwald, Ilona, et al.
Publicado: (2013)

Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients
por: Schikowski, Artur, et al.
Publicado: (2014)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

A Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain
por: Mercier, François, et al.
Publicado: (2014)

Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes
por: Tedeschi, Anna, et al.
Publicado: (2018)

Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data
por: Schwittay, Andreas, et al.
Publicado: (2020)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Diversion and Illicit Sale of Extended Release Tapentadol in the United States
por: Dart, Richard C., et al.
Publicado: (2016)

Repeated Administration of Clinically Relevant Doses of the Prescription Opioids Tramadol and Tapentadol Causes Lung, Cardiac, and Brain Toxicity in Wistar Rats
por: Barbosa, Joana, et al.
Publicado: (2021)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol immediate release: a new treatment option for acute pain management
por: Afilalo, Marc, et al.
Publicado: (2010)

Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis
por: Franco-de la Torre, Lorenzo, et al.
Publicado: (2023)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4gahucqvpqjttkv1gh4g4bce3o